Cross-institution positioning
Oct 7, 2026Strong institutional reduction. 2 accumulating, 4 exited across 6 comparable institutions.
Source: Schedule 13 researchBaldwin Insurance Group, Inc.
Latest stored close $31.87 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 2 accumulating, 4 exited across 6 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; Latest classified evidence: Financial statements / exhibits. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +29.9% YoY; Net income -1,132.5% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 99% through its reported 52-week range; +8.0% over one year.
Source: Stored historical price seriesFiled Oct 7, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Matas Barbara Ruth | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | SULLIVAN CHRIS THOMAS | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Shook Ellyn | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Muthukrishnan Sathish | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Cohen Jay A | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Sparks Paul Eugene | FTax/price withholding or payment | Class A Common Stock | 244 | $31.77 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Sparks Paul Eugene | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Parasuraman Sunita | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | KADOW JOSEPH JOHN | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Oct 1, 2026 | Williams Myron K | AGrant, award, or other acquisition | Class A Common Stock | 824 | $0.00 | Direct | Oct 2, 2026 |
| Jul 1, 2026 | Williams Myron K | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | SULLIVAN CHRIS THOMAS | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Shook Ellyn | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Sparks Paul Eugene | FTax/price withholding or payment | Class A Common Stock | 416 | $26.91 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Sparks Paul Eugene | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Parasuraman Sunita | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Muthukrishnan Sathish | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Matas Barbara Ruth | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | Cohen Jay A | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
| Jul 1, 2026 | KADOW JOSEPH JOHN | AGrant, award, or other acquisition | Class A Common Stock | 1.2K | $0.00 | Direct | Jul 2, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 9, 2026 | 8-K | 9.01 | Financial statements / exhibits | — | Filing |
| Sep 21, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Sep 14, 2026 | 8-K | 1.01, 7.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 30, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 4, 2026 | 8-K | 5.02, 5.07 | Director or executive change; Shareholder vote results | — | Filing |
| May 4, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Feb 27, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Feb 26, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 2, 2026 | 8-K | 9.01 | Financial statements / exhibits | — | Filing |
| Jan 2, 2026 | 424B7 | — | Prospectus filing | Capital-related | Filing |
| Jan 2, 2026 | 8-K | 1.01, 2.01, 2.03, 3.02, 5.02, 9.01 | Material definitive agreement; Acquisition or disposition of assets; New direct financial obligation; Unregistered sale of equity securities; Director or executive change; Financial statements / exhibits | Equity | Filing |
| Dec 2, 2025 | 8-K | 1.01, 3.02, 7.01, 9.01 | Material definitive agreement; Unregistered sale of equity securities; Regulation FD disclosure; Financial statements / exhibits | Equity | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $488.8M | +29.9% |
| Ended Mar 31, 2026 | $528.9M | +28.8% |
| Ended Sep 30, 2025 | $362.3M | +8.1% |
| Ended Jun 30, 2025 | $376.2M | +11.6% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $1.5B | +8.5% |
| Ended Dec 31, 2024 | $1.4B | +13.6% |
| Ended Dec 31, 2023 | $1.2B | +23.6% |
| Ended Dec 31, 2022 | $980.7M | +72.9% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Sep 30, 2026 observed Oct 7, 2026 filed · 7d Schedule 13G amendment | Exit below reporting threshold | 2.9M +2.9M | 3.00% -12.00 pts | $31.79 | $31.83 | $31.87 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 26, 2026 filed · 13d Schedule 13G amendment | Exit below reporting threshold | 0 -6.1M | 0.00% -9.50 pts | $21.06 | $21.68 | $31.87 |
| Capital Research Global Investors CIK0001422848 | Dec 31, 2025 observed Feb 12, 2026 filed · 43d Schedule 13G amendment | Reported accumulation | 71.6M +948.3K | 12.00% 0.00 pts | $24.03 | $16.76 | $31.87 |
Compare BWIN with other securities showing similar institutional activity or recent accumulation across several tracked institutions.